Article Information
PubMed
Published By
History
- Received November 11, 2015
- Revision received January 28, 2016
- Accepted February 21, 2016
- First published April 27, 2016.
- Version of record published April 27, 2016.
Copyright & Usage
Copyright © 2016 the authors 0270-6474/16/364698-10$15.00/0
Author Information
- Malena B. Rone1,*,
- Qiao-Ling Cui1,*,
- Jun Fang2,
- Li-Chun Wang2,
- Ji Zhang1,3,
- Damla Khan1,
- Melissa Bedard1,
- Guillermina Almazan2,
- Samuel K. Ludwin1,
- Russel Jones4,
- Timothy E. Kennedy1, and
- Jack P. Antel1
- 1Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada,
- 2Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada, and
- 3Alan Edwards Centre for Research on Pain and
- 4Department of Physiology, McGill University, Montreal, Quebec H3A 0G4, Canada
Author contributions
Author contributions: M.B.R. and Q.-L.C. designed research; M.B.R., Q.-L.C., J.F., L.-C.W., and M.B. performed research; M.B.R., Q.-L.C., and J.Z. contributed unpublished reagents/analytic tools; M.B.R., Q.-L.C., D.K., G.A., S.K.L., R.J., T.E.K., and J.P.A. analyzed data; M.B.R., Q.-L.C., J.Z., G.A., S.K.L., R.J., T.E.K., and J.P.A. wrote the paper.
↵*M.B.R. and Q.-L.C. contributed equally to this study.
Disclosures
- Received November 11, 2015.
- Revision received January 28, 2016.
- Accepted February 21, 2016.
This work was supported by an operating grant from the MS Society of Canada. M.B.R. was supported by a postdoctoral fellowship from the MS Society of Canada.
The authors declare no competing financial interests.
- Correspondence should be addressed to Jack P. Antel, Neuroimmunology Unit, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec H3A 2B4, Canada. jack.antel{at}mcgill.ca
Online Impact
Article usage
In this issue
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival
